«Ich bin der festen Überzeugung, dass Pharmaunternehmen viel mehr tun können, als Medikamente herstellen» (Blog)
https://www.swisstph.ch/de/impact-stories/i-believe-that-pharmaceutical-companies-can-do-more-than-providing-medicines/blog-id/84
Lutz Hegemann, Präsident Global Health & Sustainability von Novartis, ist seit 2023 Mitglied des Swiss TPH-Kuratoriums. Im Interview erklärt er uns, warum er als Arzt zur Pharmaindustrie wechselte, wi
When epidemiologists become detectives: Interview with Helena Greter (Blog)
https://www.swisstph.ch/de/impact-stories/when-epidemiologists-become-detectives-interview-with-helena-greter/blog-id/82
Helena Greter, Leader of the Competence Centre for Epidemiological Outbreak Investigations at Swiss TPH, talks about the role of the competence centre, looks at current outbreaks in Switzerland and ex
Weiterbildungsstudiengänge (MAS, DAS & CAS) | Studieren am Swiss TPH (Page)
https://www.swisstph.ch/de/studienangebot/weiterbildung/mas-das-cas
Weiterbildungsstudiengänge am Swiss TPH – MAS, DAS und CAS Am Swiss TPH bieten wir Ihnen herausragende Master-, Diplom- und Zertifikatsstudiengänge (MAS, DAS und CAS) in Global Health und Management a
Genotyping Group | Malaria Research at Swiss TPH (Page)
https://www.swisstph.ch/de/about/med/medicines-development/genotyping
Group | Genotyping Medicine Medicines Development Unit Diagnostic Development Genotyping Molecularimmunology Malaria molecular surveillance (MMS) is increasingly being implemented in malaria endemic c
Kommunikation (Page)
https://www.swisstph.ch/de/about/dir/communications
Kommunikation Die Communications Unit koordiniert die Medienarbeit, organisiert Symposia und Events, veröffentlicht den Jahresbericht und andere Publikationen, und betreut die Swiss TPH Website und So
Cancer Disparities | Research at Swiss TPH (Page)
https://www.swisstph.ch/de/about/eph/society-gender-and-health/cancer-disparities
Group | Cancer Disparities Epidemiology and Public Health Society, Gender and Health Cancer Disparities Gender and Inequities Cancer is the leading cause of morbidity and mortality: about 1 in 5 peopl
World Malaria Day 2024: Work together and accelerate the fight! (Page)
https://www.swisstph.ch/de/impact-stories/world-malaria-day-2024-work-together-and-accelerate-the-fight
Let me just share two examples, which show that progress is possible when people across cultures, sectors and systems work together to translate research into action and make a difference. The first e
Noma: giving a face to a deadly disease (Page)
https://www.swisstph.ch/de/impact-stories/noma-giving-a-face-to-a-deadly-disease
Many people prefer to look the other way when it comes to this disease, as the sight of young children suffering from its effects is unbearable. It causes open wounds on the face and whole sections of
Water, Sanitation and Hygiene (Page)
https://www.swisstph.ch/de/topics/environment-and-health/water-sanitation-and-hygiene
Water, Sanitation and Hygiene Swiss TPH works on aspects of water, sanitation and hygiene (WASH) in countries where drinking water is scarce and where poor hygiene is a leading cause of infectious dis
Investigations of the metabolites of the trypanocidal drug melarsoprol (Publications)
BACKGROUND: Melarsoprol remains the first-choice drug for trypanosomiasis (human African sleeping sickness). To contribute to the sparse pharmacologic data and to better understand the cause of the fr